A common remedy for nasal congestion—the nasal decongestant spray—may actually worsen symptoms if used beyond five days, according to the Medicines and Healthcare products Regulatory Agency (MHRA). This revelation highlights a critical health risk associated with overuse of these widely available treatments.

What Is Rebound Congestion and Why Does It Matter?
Nasal decongestant sprays provide rapid relief from stuffy noses caused by colds, allergies, and sinus infections. However, prolonged use can trigger a condition called rebound congestion, medically known as rhinitis medicamentosa. The Royal College of Pharmacy (RCP) describes this as a preventable cycle where symptoms not only return but worsen, creating dependence on the spray itself.
Essentially, instead of resolving the underlying cause of nasal blockage, extended use of sprays containing active ingredients like xylometazoline and oxymetazoline irritates the nasal passages. This irritation leads to swollen nasal tissues and persistent congestion, forcing users to apply the spray repeatedly to alleviate the discomfort.
New Guidelines and Packaging Changes
In response to these concerns, the MHRA announced that all nasal sprays and drops containing these decongestants must now include a warning advising users not to exceed five days of continuous use. This is a stricter guideline than the previous recommendation of up to seven days, which was advocated by the RCP in January.
While the MHRA acknowledges that updating packaging and leaflets will take several months, they urge consumers to adhere to the five-day limit immediately. This proactive approach aims to reduce the incidence of rebound congestion and prevent unnecessary harm.
Thao Huynh, head of respiratory imaging and critical care at the MHRA, emphasized the risks: “If your nose remains blocked after five days of using a nasal spray, it is likely caused by overusing the product rather than the original illness. Continuing use can exacerbate the issue.” He advises patients who experience ongoing symptoms to consult healthcare professionals about discontinuing the spray and exploring alternative treatments.
Huynh reassures that when used correctly, these sprays are both safe and effective. He encourages users to carefully read the information leaflets and packaging to understand proper usage.
Pharmacists Call for Greater Public Awareness
The Royal College of Pharmacy conducted research revealing that nearly 60% of pharmacists believe many patients remain unaware of the dangers linked to prolonged nasal spray use. This knowledge gap contributes to misuse and increased risk of rebound congestion.
Professor Amira Guirguis, chief scientist at the RCP, advocates for clearer labeling and consistent public messaging. “Improved packaging and straightforward product information are essential to alert users that these sprays are intended strictly for short-term use,” she stated. “Such measures will help avoid preventable harm and reduce dependency on these medications.”
Why This Warning Is Critical for Consumers
The widespread availability of nasal decongestant sprays—often sold over the counter without prescription—makes public education vital. Many users perceive these sprays as harmless quick fixes, unaware that extended use can lead to a worsening cycle of congestion and dependency.
With millions turning to these products during cold and allergy seasons, the MHRA’s new guidance aims to curb the unintended consequences of misuse. By highlighting the five-day limit and promoting professional consultation for persistent symptoms, health authorities seek to protect consumers from chronic nasal issues.
Looking Ahead: Safer Use and Alternatives
Healthcare professionals recommend that anyone experiencing nasal blockage lasting longer than five days should seek medical advice rather than continuing spray use. Alternative treatments, such as saline nasal sprays, steam inhalation, or addressing underlying allergies, may offer safer relief.
Ultimately, this updated guidance serves as a crucial reminder that even common, over-the-counter medications can carry risks if not used responsibly. Patients and caregivers must stay informed to avoid turning a simple remedy into a persistent health problem.
Takeaway: Nasal decongestant sprays remain valuable for short-term symptom relief but must not be used for more than five consecutive days. Awareness of rebound congestion and adherence to new labeling warnings will help prevent dependency and worsening nasal blockage. If symptoms persist, consulting a healthcare professional is essential to explore safer, effective alternatives.









